A Most Favored Nation clause sounds fair — your earliest believer gets whatever better deal you give the next investor. In practice, it means every cap you negotiate downward for a later check can silently reprice money you already banked. You lose negotiating room before the conversation starts.
Reading time: 7 minutes. The worked example shows how an $8M cap MFN SAFE reprices to a $6M cap — no new cash, same investor, worse cap table for you.
MFN stands for Most Favored Nation. In a fundraising context, it means: if you give a later investor better economic terms — a lower valuation cap, a higher discount, or other concessions — an earlier investor with MFN can elect to swap onto those terms retroactively.
The clause protects the earliest check-writer. They took the most risk when you had the least proof. MFN is their insurance against you running a party round where every new angel gets a sweeter cap. For them, it is rational. For you, it is a constraint on every future SAFE you sign until that MFN is satisfied or waived.
Y Combinator publishes an MFN variant of its post-money SAFE. Many seed investors request MFN on the first $250k–$500k when they are genuinely first in. The problem is not MFN existing — it is MFN granted broadly, without a look-back window, across a round where you plan to negotiate different caps for different investors.
When you issue a later SAFE with better economics, the MFN holder gets notice (per the contract) and a window to elect the new terms. If they elect, their original investment converts as if it had been made at the lower cap or higher discount — without them wiring more money.
Typical MFN scope covers valuation cap and discount on subsequent SAFEs in the same financing round. It does not usually reach into a priced Series A, but read the actual language — customised side letters can broaden the trigger.
What changes for you: every cap you lower for a new angel is a potential reprice event for every MFN holder. Stack two MFN SAFEs at $8M, then close a strategic at $6M, and both early checks reprice — not just the new one. Your fully-diluted ownership drops twice on the same round of fundraising.
MFN does not create new cash. It redistributes ownership from founders (and non-MFN holders) to MFN holders. The total raise stays the same; the cap table math changes after the fact.
You close Investor A on a $400k post-money SAFE at an $8M cap with MFN. On a post-money SAFE, ownership is locked at signing: $400k ÷ $8M = 5.0%.
Three months later, traction improves and you close Investor B at $6M cap (no MFN) for $300k — 5.0% for them. You needed the lower cap to land the check. Reasonable negotiation.
Investor A elects MFN. Their $400k now converts as if the cap were $6M: $400k ÷ $6M = 6.67% — an extra 1.67 percentage points of your company, for money already in the bank. No new wire. No new value-add. Just a clause doing its job.
Cost to you: 1.67% of fully-diluted ownership, before the Series A, option pool refresh, or any other SAFEs. On a $20M Series A exit, that 1.67% is roughly $334k of proceeds — illustrative, but the order of magnitude is real. Grant MFN to three early angels and reprice all of them on one $6M strategic: the stack compounds.
MFN makes sense for the first institutional or lead angel who priced your risk when nobody else would. It does not make sense for the fifth $50k check in the same party round. Broad MFN across a round removes your ability to tier caps by check size, strategic value, or timing.
Negotiate MFN that expires after 12–18 months or covers only the current financing round. Some founders limit MFN to cap only (not discount) or exclude strategic investors. If the investor will not narrow scope, treat that as a signal about how they will behave at Series A.
Before every new SAFE, ask: "If I give this cap, who with MFN elects?" If the answer is anyone, rerun the cap table. Founders who skip this step get surprised at conversion — when it is too late to renegotiate.
Default for pre-seed party rounds: no MFN unless there is a single clear first believer. If you must grant it, keep it narrow, time-boxed, and model the reprice before every subsequent check.
Drop the SAFE or side letter in. Prism extracts: MFN presence, scope (cap, discount, or both), election window, and which instrument class it attaches to. It cross-references other SAFEs in your playbook and flags when a proposed new cap would trigger a downward reprice for existing MFN holders.
The output: a severity-rated finding when MFN plus your other SAFEs imply a reprice event, with the ownership delta in percentage points — not a generic warning that "MFN exists." If your playbook caps seed SAFEs at $8M and a side letter pairs MFN with a $6M strategic already in the data room, you see the conflict before you send the doc.
Your rules, applied to this specific document, with the math that turns "we always give MFN to early angels" from a habit into a quantified cap-table decision.
Prism reads a contract and checks it against your own playbook. One plan, €49 a month, no free tier. The details are on the pricing page.
Pro rata rights — an investor's right to keep their ownership percentage in later rounds.
SAFE vs convertible note — interest, maturity and the other differences that decide which instrument to sign.
SAFE discount rate — the other lever besides the cap, and which one wins at conversion.
Valuation cap, in plain English — the price ceiling at which your SAFE converts, and how to defend a fair one.
Browse the whole glossary. If there's a term you're trying to understand right now and it's not here, tell us — the order we write these in is driven by what founders ask for.
